[Indication and side effect of alpha glucosidase inhibitor].
Katahira
Hiroshi
H
Third Department of Internal Medicine, Kyorin University School of Medicine.
Ishida
Hitoshi
H
D020909:Acarbose / Q000008:administration & dosage / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D000075202:Contraindications; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000139:chemically induced; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D022124:Hyperammonemia / Q000139:chemically induced; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007294:Inositol / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D018579:Patient Selection
D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007294:Inositol; C102817:voglibose; D020909:Acarbose